ABUS CIK: 1447028

Arbutus Biopharma Corp

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−73.5
FY22:
−65.5
FY23:
−78.1
FY24:
−76.3
FY25:
−38.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−76.2
FY22:
−69.5
FY23:
−72.8
FY24:
−69.9
FY25:
−33.5

All amounts in millions USD Data source:SEC EDGAR